Overview

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

Status:
Recruiting
Trial end date:
2025-09-18
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of twice-daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in the treatment of participants with moderate to severe chronic hand eczema (CHE).
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma